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Abstract
Background: Stoichiometric imbalances in macromolecular complexes can lead to altered function. Such imbalances
stem from under- or over-expression of a subunit of a complex consequent to a deletion, duplication or regulatory
mutation of an allele encoding the relevant protein. In some cases, the phenotypic perturbations induced by such
alterations can be subtle or be lacking because nonlinearities in the process of protein complex assembly can provide
some degree of buffering.
Results: We explore with biochemical models of increasing plausibility how buffering can be elicited. Specifically, we
analyze the formation of a dimer AB and show that there are particular sets of parameters so that decreasing/
increasing the input amount of either A or B translates into a non proportional (buffered) change of AB. The buffer
effect also appears in higher-order structures provided that there are intermediate subcomplexes in the assembly
process.
Conclusions: We highlight the importance of protein degradation and/or conformational inactivation for buffering to
appear. The models sketched here have experimental support but can be further tested with existing biological resources.
Reviewers: This article was reviewed by Eugene Koonin, Berend Snel and Csaba Pal.
Keywords: Aneuploidy, Haploinsufficiency, Trisomy, Gene deletion, Gene duplication, Polyploidy
Background
Stoichiometric change in a macromolecular complex can
induce altered function. Consistently, subunits of such
complexes tend to have similar expression levels, most of
the time assessed at the transcriptional level [1, 2]. This
property stems from principles of cellular economy, but
also, as explained below, as a requirement to avoid the for-
mation of inactive sub-complexes when there is an imbal-
ance in the concentration of one or several subunits. For
instance, dosage effects within macromolecular complexes
or even between transcription factors (TFs) and their cog-
nate cis-regulatory target sequences explains, at least in
part, the extensive retention of paralogs in polyploids [3, 4].
To gain insight into the biochemical bases of the ef-
fects of stoichiometric imbalances, we explore the conse-
quences of under- or over-expression of a subunit of a
complex due, for instance, to a deletion, duplication or
regulatory mutation of an allele encoding the relevant
protein in a diploid organism. In such cases there is an
imbalance that increases the concentration of unpart-
nered subunits. The deficit of one binding partner leaves
the remaining partners in (relative) excess. When this
situation engenders a dominant phenotype we speak of
haploinsufficiency (HI). The molecular bases of HI can
be diverse, depending on the systems under consideration
[5]. In the case of macromolecular complexes, the explan-
ation of some cases of HI is almost intuitive. For instance,
if the complex is a trimer that contains 2 molecules of A
and one molecule of B, the effect of a decrease in the con-
centration of A is probably more dramatic than for B, as
shown in Fig. 1. However, as also shown in this figure, the
result depends on the topology of the complexes [5, 6].
These examples epitomize why the expression levels of
the subunits of a complex evolve to be co-regulated. Al-
though most of what follows focuses on situations arising
in diploid organisms, it is worth saying that the dosage
balance principles hold also for prokaryotes. Indeed, a
systematically analysis of macromolecular complexes
from E. coli has shown that more than half of the
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relevant molecules are synthesized at levels (counted as
molecules per generation) very well correlated with their
stoichiometry within the complexes [7]. This proportional
synthesis out of a polycistron relies on translational tuning
[7, 8]. Not surprisingly, similar results have been found for
stable complexes from S. cerevisiae [7].
Monomers in absolute or relative excess can be either
not in their final conformation, misfolded or at least expose
interfaces, which mediate protein-protein interactions, that
should normally be hidden within the complex. Such inter-
faces tend to be rich in hydrophobic residues that contrib-
ute to protein-protein association [9]. Chaperons may
protect the exposed interfaces and hide them from the
aqueous surroundings. Monomers in excess can also ex-
pose normally buried degradation signals, which can lead
to their efficient degradation [10]. In other cases, subunits
in excess may expose hydrophobic or aggregation-prone
regions that may lead to their aggregation and accumula-
tion. Hence HI of subunits of macromolecular complexes
can be due to plain insufficiency of the complex per se but
can also lead to abnormal molecular interactions resulting
in misfolding or aggregation. This can obviously be the
case for overexpressed isolated subunits [11, 12].
It is well known that genetic dominance is a matter of
non-linearity in the relationship between the genotype
and the phenotype [5, 13]. Dosage imbalances can be
expressed as dominant traits at the phenotypic level as
illustrated in general by aneuploidy [14]. In some cases,
the phenotypes due to gene deletions, duplications or
misregulation can be subtle or lacking because nonline-
arities in the process of complex assembly can provide
some degree of buffering. In line with this, a previous
analysis of the formation of a heterodimer AB, has
shown that halving the input amounts/concentrations of
A or B (i.e. A0 and B0, provided that they are equal in
normal conditions) does not always translate into halv-
ing the amount of AB. This analysis was based on a
dimerization reaction involving similar initial “full
blown” concentrations of A and B as if the reaction was
taking place in a test-tube. Interestingly, there is a par-
ticular value of the dissociation constant so that halving
A0 (or B0) translates into the production of 59 % of
dimer AB. This particular dissociation constant is of the
order of A0/4 (or B0/4). This behavior was referred to as
the buffer effect of equilibrium and has a similar explan-
ation as a trivial chemical buffer [15]. As shown below,
the gain of almost 10 % of AB may be particularly im-
portant in cooperative systems where a small change of
effector concentration can elicit huge changes in the re-
sponse [5, 16]. This buffer effect suggests that the associ-
ation constant and the concentration of the partners can
be tuned by selection so as to make the system robust
against halving the input of one of its components.
However, taking advantage of this buffer effect implies
the existence of unused free monomers. Interestingly, in-
creasing the input concentration of either A or B (1.5
times as in a heterozygous gene duplication) for the
same dissociation constant translates into 138 % of AB
with respect to normal conditions (instead of 150 %).
Thus, the buffer effect works in both directions (i.e.
gene-dosage increase or decrease) and also appears in
higher order structures provided that there are subcom-
plexes in equilibrium [15]. Notice that a maximum de-
gree of buffering of the amount of AB is a focal effect and
does not imply any kind of notion of ‘optimality’. Optimal
functioning should be defined from the perspective of a
“wild-type” (WT) individual in a particular environment
and cannot be reduced to the amount of AB in isolation.
Below, we explore the potential existence of buffering ef-
fects in situations of increasing plausibility, extending our
previous views [17].
Results and discussion
The effect of protein degradation and/or conformational
inactivation on buffering
We will now analyze the assembly of a protein complex,
namely the dimer AB, in irreversible conditions, when
A
+ = + =
+ = + =
( is a bridge)
B ( is not a bridge)
Normal condition halved
Normal condition halved
Fig. 1 Complex topology and dosage sensitivity. a Case of a trimer
in which the green subunit is a bridge. Halving of the latter leads to
halving trimer output. However, halving the amounts of the orange
subunits can lead to as low as 25 % of trimer. Overexpression of the
orange subunits can be inconsequential from the perspective of the
trimer output but entails a futile cost, whereas overexpression
of the green ones leads to a titration effect (formation of dimeric
subcomplexes), which reduces trimer output. b When the orange
subunits can, for instance, preassemble, halving their amount
translates into a proportional decrease of trimer and the increase of
the green ones does not alter the amount of trimer. This shows
how the topology of the complex and not only its composition
modulate dosage sensitivity
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the amount of one subunit is decreased or increased, ac-
cording to the reaction scheme represented in Fig. 2a.
We focus first on this rather artificial system involving
initial fixed amounts of A and B in order to more easily
dissect the impact of the competing reactions, namely
dimerization and degradation, on the level of buffering.
This model would apply, for instance, to a situation in
which there is a rapid burst of production of A and B and
in which AB is more stable than the free monomers,
which might expose degradation signals. Thus, we com-
pare what happens to AB in the WT condition where A0
= B0 (by virtue of ideal dosage balance) to extreme condi-
tions in which the dose of either A or B is increased (1.5x
as in an ideal case of a heterozygous gene duplication) or
halved (heterozygous deletion). We can also envisage an
alternative to protein degradation by supposing that both
A and B have a preferential conformation to interact with
each other (i.e. AI and BI in Fig. 2b). Indeed, the 3D struc-
ture of an isolated monomer can differ from its
conformation when it is complexed with binding partners
forming an oligomer [18]. This is epitomized by the interac-
tions between domains of the cAMP response element
binding protein (CREB-binding protein or CBP) and the ac-
tivator for thyroid hormone and retinoid receptors
(ACTRs) [19]. Both the ACTR and the CBP domains are
intrinsically unfolded in isolation but their co-expression
leads to a stoichiometric structured complex. Thus, the as-
sembly of a complex may involve unstable intermediates
(i.e. “conformational transition states”) that undergo
stabilization as oligomerization proceeds. This process has
also been termed “interdependent protein dance” [20, 21].
If there is a stoichiometric imbalance, the monomer in ex-
cess may have time to transit for a preferred-for-binding to
a nonpreferred conformation (inactive for binding). Thus,
the steps AI - > AII and BI - > BII in Fig. 2b are formally
equivalent to their degradation.
In our biochemical simulations, we consider for
simplicity that degradation is linear and that the specific
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150% A
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Fig. 2 Buffer effects in the assembly of a heterodimer. a The monomers A and B are involved in competing reactions: their degradation or
their dimerization. b Alternative scenario in which both A and B have a preferential conformation to interact with each other (i.e. AI and BI).
Conformations AII and BII do not lead to dimers. Note that the parameters of synthesis and degradation encapsulate information on both mRNA
and protein in this simplified model, but we assume that no buffering occurs at the transcriptional level. c Buffering response of heterodimer AB
formation to changing the input concentration of one monomer. As mentioned in the text, here we consider for simplicity that A and B are
synthesized in a very short time scale compared to the rest of the reactions. So we deal with input concentrations and not with parameters of
synthesis (as will be the case in Fig. 3). The ordinates represent the % of AB when either A0 or B0 are changed (0.5X or 1.5X, "mutated" condition)
with respect to A0 = B0 ("wild-type", wt). The results were obtained with the biochemical simulator GEPASI, which solves numerically the chemical
and the underlying differential equations [40]. If normally A0 = B0 = 1nM, DA =DB (here called D) and kAB > > D, at a specific D/kAB value, halving
the input amount of either monomer (upper panel) leads to >57 % of dimer in such (rather artificial) conditions of irreversibility. Operating at the same
D/kAB value leads to 123 % of AB output when A0 or B0 are increased by 150 %. d Response of heterodimer AB formation to changing the
input concentration of one monomer (when one of them can be degraded and the other not). In this case A0 = B0 = 1nM, DA = 0.01 min−1
and DB = 0 min−1
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degradation rates (D) are identical. As shown in Fig. 2c,
an interesting phenomenon appears when the initial
concentration of either A0 or B0 is halved. In that case,
the degree of buffering reaches a maximum level, when
D/kAB (where kAB is the specific dimerization rate) is
of the order of A0/5. In such conditions, halving the
amount of A0 or B0 leads to a residual amount of 58 %
of AB instead of 50 %. This point corresponds to a de-
gree of overexpression of 123 % of AB for a 150 % in-
crease of either A0 or B0, showing again that the buffer
can act in both directions. This relationship is remark-
ably similar to the one mentioned above, for equilibrium
conditions (i.e. the maximum buffering for a deletion ap-
pears at Kdissociation = A0/4) even if the mechanistic
bases are totally different. Again, the existence of the
buffer effect implies the existence of some excess of
monomers. In the equilibrium model the buffer effect
appear at the expense of the existence of uncomplexed
mononomers, in the irreversible conditions, it relies on
monomer degradation. According to the conformational
inactivation scenario outlined above, when B0 is halved,
at each time-point there will be an excess of A that can
reach the inactive-for-binding conformation AII.
The passive buffering effect outlined here relies on the
existence of degradation or conformational inactivation
of the monomers in competition with dimerization. The
importance of the degradation/inactivation reactions can
be better appreciated in an asymmetric model, where
one monomer is degradable and the other is not. As
shown in Fig. 2d, in such conditions, changes of B0 (the
nondegradable entity) are much better buffered than
changes in A0 and, of course, in the absence of degradation
of both there is no buffering at all. This asymmetric
example also shows that even in the simplest case of
dimers each monomer can have different dosage sensi-
tivities (depending on the parameter settings of the
system). From the perspective of the conformational
inactivation scenario, monomer B can be considered as
a rapid and autonomous folder (i.e. it reaches alone its
final conformation). Because it provides information
for the folding of A, its insufficiency will lead to the in-
active conformation AII.
The buffer effect in realistic conditions
In order to explore this question, the synthesis of each
monomer will be represented by the fluxes SA and SB.
Their degradation will be considered again as a linear
process governed by the rate constants DA, DB and DAB. As
above, properly speaking, S and D contain information on
mRNA/protein production and degradation, respectively.
Because we want to focus on what happens at the protein
level only, we must assume that the processes of transla-
tion and degradation of the mRNA encoding A and B
are strictly proportional to their concentrations. Thus,
gene deletions or duplications can be easily modeled by
changing S or D (Fig. 3a). For simplicity, we will focus on
the steady-state. By using numerical simulations, as per-
formed in the previous section, it is difficult to detect
the parameter(s) modulating the buffering capacity in
the steady state (if the buffer exists at all). For this rea-
son, we solved the differential equations describing the
system in the steady state (i.e. when dA/dt = dB/dt = dAB/
dt = 0). The steady-state concentration of AB is given by
the following formula:
AB½  ¼ 1
2DAB
SA þ SB þ DADBkAB −
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ








With this equation in hand, it is easier to grasp the
candidate terms/parameters that should play a role in a
potential buffer effect. Our question reduces to deter-
mining the maximum of the fraction AB2/AB1 when ei-
ther SA or SB have been halved with respect to the WT
situation. DAB vanishes from this fraction (i.e. is not a
candidate). Here, DAB is simply a factor that modulates
negatively the final AB output. Thus, we are left with
DADB/kAB. This ratio is called here the monomer parti-
tion constant (MPC) because it reflects the relative
strength of the competing reactions: dimerization or
degradation/inactivation. When normally SA = SB (and
DA = DB), there is a DADB/kAB value that elicits a max-
imum buffering capacity. At the point of maximal buff-
ering for a deletion (59 % of AB) only 123 % of AB is
produced when either SA or SB are increased by 150 %
(Fig. 3a). The Fig. 3b, c shows that the buffer effect exists
to different extents for rather important variations of S
(from 0.5 to 1.5 nM/min) or D from 0.01 to 0.05 min−1.
This means that according to the genotypes in a popula-
tion some individuals can be weak or strong “bufferers”
of a particular variation. For instance, according to
Fig. 3b an individual for whom SB is 1.5 nM/min will
buffer very well changes in SB but less well changes in
SA.
The above results can be extended to a more complex






Because only the MPC changes in the reversible situ-
ation, there will also be buffering, as described above.
However, now, DAB will obviously play a role because it
is involved in the MPC (and does not cancel out). A sur-
vey of the literature shows that the parameters used in
our simulations are compatible with the existence of
such buffering for some TFs (see [22–25]). However, this
assertion has to be tempered by the fact that the
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parameters for the TFs in question have been deter-
mined in vitro and that the monomers and dimers can
be involved in competing reactions (including nonspe-
cific interactions with the rest of the cell).
The importance of AB degradation for the buffering
effect when dimerization is reversible is illustrated by
Eq. 2 that we have previously explored in another con-
text [17],




In fact, when AB is not degradable, there is no buffer
effect in the steady state. This contrasts with the fact
that DAB is simply a factor that modulates AB output in
conditions of irreversibility. This also suggests that ac-
cording to the assumptions of the model, buffering is
more likely to emerge for stable degradable dimers (be-
cause for unstable dimers DAB should be high to insure
AB itself is also degraded and not only the component
monomers). However, at least in theory, buffering can also
be achieved in conditions of full reversibility.
Although not treated here, it is worth noting that for
homodimers the amount of complex in the case of a het-
erozygous deletion can range from 25 % of the normal
amount (as predicted in [17, 26]) to 50 % when MPC
values are high. In the former case there is an enhance-
ment of the deletion effect, whereas a strong MPC elicits
a linear decrease of homodimer output, which can be con-
sidered as a buffered condition with regard to the worst
situation. This behavior also applies to higher-order com-
plexes having several copies of the same monomer as the
trimer of Fig. 1. This means that the kinetics of monomer
and multimer production and of their degradation
150% SA or SB
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Fig. 3 Buffer effect in the steady-state. a Realistic model in which synthesis of both A and B is considered along with their degradation and that
of the dimer (upper panel). The lower panels represent the buffering response of heterodimer AB formation to changing the parameter DADB/
kAB. For the “normal” conditions, the parameters were: SA = SB = 1nM/min, DA = DB = 0.01 min
−1 and kAB ranged from 0.000001 to 1. Here
kAB
− = 0 because the assembly was considered to be irreversible. The ordinates represent the % of AB when either SA or SB is changed (0.5X or
1.5X) with respect to SA = SB. The results were obtained using equation 1. In such conditions when MPC = DADB/kAB ranges from SA/5 to SA/4
there is maximum buffering for deletions. As discussed in the text, the findings obtained here hold for a reversible situation (only the mathematical
expression of the MPC changes). b Buffering response of the heterodimer AB formation to changing SB (as if it varied in a population). As above,
SA = 1 and the ratio DADB/kAB = 0.25. The span of the SB values induces a (small) variation of at most 25 % of AB production in any direction with
respect to SA = SB = 1nM/min. c Buffering response of heterodimer AB formation to changing DB (as if it varied in a population). As above, kAB = 0.0004
and DA = 0.01. SA = SB = 1nM/min. The span of the DB values displayed induces a maximum decrease of 25 % of AB production with respect
to DA = DB = 0.01 min
−1
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modulate dosage sensibility along with the topology of the
complex (as shown in Fig. 1).
Potential significance of buffering for transcription factors
We can now explore what the net effect of buffering
would be if AB were a TF eliciting a strongly nonlinear
transcriptional output. The process of recognition of a
promoter P with n binding sites for AB can be repre-
sented by the global reaction P + n(AB) = P(AB)n. If we
assume that the saturation fraction of the promoters
P(AB)n/PT is proportional to transcription, then the
normalized transcriptional response TR can be approxi-
mated as the following Hill equation:
TR ¼ AB½ 
n
Kn þ AB½ n ð3Þ
where K and n are constants (see further explanations
on the assumptions in [27]). The exponent is related to
the number of binding sites per promoter and they have
been equated here for simplicity. The higher n is, the
steeper will be the sigmoid. For steep sigmoidal re-
sponses, the extra 8–9 % provided by the buffering of an
allele deletion can make the difference between an ab-
normal and a normal phenotype. Figure 4 shows how
the effect of buffering of a deletion with respect to an
unbuffered situation that elicits a TR = 0.5. In this case a
residual amount of 57 % of AB translates into TR = 0.64
when n = 4 and 0.76 when n = 8. This buffering effect
can in principle be enhanced by an extra layer of buffer-
ing provided by the fact that a TF can recognize, in
addition to its binding sites in cis-regulatory regions, other
more abundant sites throughout the accessible chromatin
(not leading to transcription, i.e. nonfunctional binding)
[28]. Indeed, models considering the existence of binding
to such sites show that the concentration of functionally-
bound TF (i.e. to cis-regulatory regions) changes by a
factor <2X when the TF concentration is either halved
or doubled [29].
Conclusions
As mentioned above, tight co-regulation has been shown
for subunits of macromolecular complexes. It should be
noted that for this co-regulation to be selected for,
buffering cannot occur to a complete extent. This is
compatible with what we observe here, even when the
system operates in the “best” buffering conditions. The
evolutionary trace left by mutations such as heterozygous
deletions or duplications will depend on their degree of
dominance (h), which ranges from 0 to 1. If h = 0, the het-
erozygote will have fitness 1 (i.e. the same as the wild-type
homozygote and the mutations will be recessive) and the
mutated alleles will persist in the population for longer pe-
riods of time. At the other extreme, if h = 1, the fitness of
the heterozygote is the same as that of the mutated homo-
zygote and the mutations will be rapidly purged from the
population. The buffering effect will more often lead to 0
< h < 1. In such conditions, even if the heterozygote has
mild defects, it can pass the normal allele on to the next
generation, whereas the mutated one will be purged from
the population when found in homozygosity. The values
of h can differ from gene to gene in the organism and for
the same gene from one organism to another. For in-
stance, it is well known, at least superficially, that mouse is
more resilient to heterozygous mutations in transcription
factors than human (i.e. the gene is HI in human but not
in mouse in laboratory conditions [5, 16]). This may be re-
lated, at least in part, to different buffering settings in
these organisms for the relevant genes. Our perspective
supposes that selection can tune the parameters of the sys-
tem to make it robust to mutations. This bears conse-
quences on the debate of whether dominance (and
multiallelic interactions) is a consequence of physiology or
has been molded by natural selection [30].
Although the above discussion has focused on diploid
organisms, it is obvious that mutations affecting transla-
tional tuning in prokaryotes will perturb dosage balance.
Such mutations can affect, for instance, the Shine-Dalgarno
ribosome-binding sequences of the various cistrons within


























Fig. 4 Potential impact of buffering of a deletion of an allele
encoding a monomer of a heterodimeric transcription factor AB.
Upper panel: Schematic representation of a target promoter with 4
binding sites for AB. Lower panel: Graph of the transcriptional
response (TR) as a function of the concentration of AB. The
“unbuffered situation” was conveniently chosen to elicit a TR = 0.5.
The effect of buffering (57 % of AB instead of 50 %) leads to
TR = 0.64 when n = 4 and 0.76 when n = 8. Thanks to the strong
nonlinearity of the sigmoid, the 7 % of buffering is amplified at the
level of TR. The following formula allows the calculation of TR in
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instance, changing a preferential codon to a non-preferred
one [31].
The model sketched here has experimental support and
can be further tested. For instance, N-terminal acetylation-
induced protein degradation is suppressed when a subunit
binds to its partners within a complex [32]. Proteomic
studies of aneuploid yeast and mammalian cells show that
the components of protein complexes encoded on the
supernumerary chromosome(s) are preferentially buffered
at the protein level [33–36]. In particular, studies with yeast
strains containing an extra chromosome per haploid gen-
ome showed that in the absence of transcriptional buffer-
ing the subunits of macromolecular complexes, including
all ribosomal subunits detected underwent substantial pas-
sive buffering (or attenuation). Interestingly, inhibition of
protein degradation led to an increase of the levels of the
proteins encoded by the duplicated genes more than the
rest of the genome and this was particularly critical for the
components of complexes [37]. Despite this overall agree-
ment in situations of overexpression of multiple genes (i.e.
in aneuploids), molecular data on buffering is lacking for
deletions. Thus, the ideal experimental test of our models
should rely on assessing protein levels for cells carrying
heterozygous single-gene deletions or duplications when
transcriptional dosage compensation is ruled out. For dele-
tions, thousands of heterozygous knock-outs in yeast [38]
and mouse (embryonic stem) cells (https://www.komp.org/,
[39]) are available for testing. However, it is difficult to
propose a typical (proteome-wide) experiment because the
expected results depend on an extensive knowledge of the
stoichiometry as well as the topology of the complexes,
which are often unknown.
Methods
Steady-state solution when the reaction of production of
AB is irreversible
In order to obtain the steady-state solution for the reac-
tion scheme of Fig. 3a, we solve the differential equations
describing the system so that dA/dt = dB/dt = dAB/dt = 0.
dA
dt
¼ SA−kABA⋅B−DA⋅A ¼ 0 ð4Þ
dB
dt
¼ SB−kABA⋅B−DB⋅B ¼ 0 ð5Þ
dAB
dt
¼ kABA⋅B−DABAB ¼ 0 ð6Þ
In addition, we have that:
SA ¼ DA⋅Aþ DABAB ð7Þ
SB ¼ DB⋅Bþ DABAB ð8Þ
We solve AB from equation 6 by replacing A and B
from Eqs. 7 and 8.






SA−DAB:ABð Þ SB−DAB:ABð Þ−DABAB
0 ¼ kAB
DADB
SASB−DAB:AB:SA−DAB:AB:SB þ DAB2 :AB2
 
−DABAB


















0 ¼ AB2− 1
DAB







One of the solutions of this quadratic equation gives
the steady-state value of AB:
ABss ¼ 12DAB 
SA þ SB þMPC−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SA þ SB þMPCð Þ2−4SASB
q 
Eq: 1
Steady-state solution when the reaction of production of
AB is reversible
The set of differential equations changes to incorporate
the term of AB dissociation (whose specific rate constant
is represented by kAB−):
dA
dt
¼ SA−kABA:Bþ kAB−AB−DA:A ¼ 0 ð9Þ
dB
dt
¼ SB−kABA:Bþ kAB−AB−DB:B ¼ 0 ð10Þ
dAB
dt
¼ kABA:B−kAB−AB−DABAB ¼ 0 ð11Þ
We solve for AB as described above.
0 ¼ kAB
DADB
SA−DAB:ABð Þ SB−DAB:ABð Þ− kAB− þ DABð ÞAB
0 ¼ SASB−DAB:AB:SA−DAB:AB:SB þ DAB2 :AB2
−
kAB− þ DABð ÞDADB
kAB
:AB
0 ¼ DAB2 :AB2−AB DABSA þ DABSB þ







0 ¼ AB2− AB
DAB
SA þ SB þ kAB







After solving this quadratic equation we obtain the
steady-state value of AB which has the same form as Eq. 6
with
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MPC ¼ kAB− þ DABð ÞDADB
DABkAB
ð12Þ
When the reaction of production of AB is reversible and
AB is not degradable
dA
dt
¼ SA−kABA:Bþ kAB−AB−DA:A ¼ 0 ð13Þ
dB
dt
¼ SB−kABA:Bþ kAB−AB−DB:B ¼ 0 ð14Þ
dAB
dt
¼ kABA:B−kAB−AB ¼ 0 ð15Þ
The conservation of fluxes are as follows:
SA ¼ DA:A ð16Þ
SB ¼ DB:B ð17Þ
We solve AB from equation 15 by replacing A and B
from Eqs. 16 and 17. This is another way to derive the
same result already described in ref. 15.











First of all we would like to thank the referees for their
comments and suggestions that were addressed as follows:
Reviewer’s report 1
Reviewer 1: E. Koonin
Reviewer’s comment
Mechanisms and evolution of dosage compensation are
fascinating and important subjects. This paper provides very
simple but, to my knowledge, new and valid models of the
buffering effect. This is quite useful, especially as simple,
feasible tests are proposed.
A quick comment. The discussion in the article fo-
cuses on dominance that is only relevant in diploid or-
ganisms. How does the model apply to haploids such as
most prokaryotes?
Authors’ response: Although the MS focuses on situa-
tions arising in diploid organisms, the dosage balance
principles hold also for prokaryotes. Indeed, a systemat-
ically analysis of macromolecular complexes from E. coli
has shown that more than half of the relevant molecules
are synthesized at levels (counted as molecules per gen-
eration) very well correlated with their stoichiometry
within the complexes. This proportional synthesis out of
a polycistron relies on translational tuning. Li G-W,
Burkhardt D, Gross C, Weissman JS: Quantifying abso-
lute protein synthesis rates reveals principles underlying
allocation of cellular resources. Cell 2014, 157:624–635.
And another point. The authors indicate that balance
between subunits is controlled at the levels of transcrip-
tion and protein degradation. However, translational
control seems to be important as well, see eg. Quax TE,
Wolf YI, Koehorst JJ, Wurtzel O, van der Oost R, Ran
W, Blombach F, Makarova KS, Brouns SJ, Forster AC,
Wagner EG, Sorek R, Koonin EV, van der Oost J. Differ-
ential translation tunes uneven production of operon-
encoded proteins. Cell Rep. 2013 Sep 12;4(5):938–44.
Authors’ response: We have included this reference
and discussed it in the text.
Reviewer’s report 2
Reviewer 2. Berend Snel
The manuscript of Veitia and Birchler presents a novel
and general model for protein complex formation. Interest-
ingly even without most other cellular processes taken into
account (such as transcriptional buffering or post-
transcriptional buffering) the authors show that there is
already counterintuitive behavior. However I also have
some reservations about this manuscript which I detail
below.
1) The model does not seem to connect to any concrete
or specific biological question or challenge, such as for ex-
ample a growth phenotype we cannot explain or a regula-
tory mutation that has a less strong phenotype than
expected. In the discussion the authors discuss the haploin-
sufficiency differences between human and mouse, but to
me it is not clear whether there is any specific reason to
think this is due to buffering at the protein complex forma-
tion level or other levels where buffering takes place. Simi-
larly most of the examples in the paper are not examples in
the biological sense but cartoon/schematic/idealized ver-
sions of potential biological cases.
Authors’ response: The referee is correct when he says
that the model does not apply to a specific system. This
is mainly due to the lack of detailed molecular know-
ledge and also to our aim, which is basically to attract
the attention of the reader to a possible buffering effect
at the protein level. However, a survey of the literature
shows that the parameters used in our simulations are
compatible with the existence of such buffering for some
TFs (see refs [22–25]). However, as stated in the text,
this has to be tempered by the fact that the parameters
for the TFs in question have been determined in vitro
and that the monomers and dimers can be involved in
competing reactions (including nonspecific interactions
with the rest of the cell). So the problem of lack of
realistic data remains the same. Concerning the issue of
the difference of dosage senstivity between human and
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mouse, it is mentioned en passant. We do not claim that
our model is the sole explanation for that (although it
might contribute).
This absence of acute biological urgency is compounded
by the fact that protein complex formation/concentration
does not very often (that I know off) equal phenotype.
Many processes and feedback loops still exist between pro-
tein complex formation and phenotype and a simple indu-
cible transcription loop could easily provide almost perfect
buffering by simply increasing the expression of the sub-
units which is missing from one of the chromosomes.
Authors’ response: The referee is correct but the exist-
ence of feedback does not preclude the existence of other
types of less active mechanisms as the ones hypothesized
and explored here.
2) Related to the first point I also got the impression that
this paper misses a lot of context. For example one by now
classic nature paper argues that protein complex members
are not co-regulated and that the transcriptional regulation
of missing subunits would serve to regulate the entire com-
plex (just in time complex formation). In general a lot more
has happened on protein complexes and expression than
the papers from more than ten years ago which are used to
support the link between expression and protein complex
formation, see also e.g. http://www.biomedcentral.com/
1752-0509/2/1
Authors’ response: Indeed, a systematic analysis of
macromolecular complexes from E. coli has shown that
more than half of the relevant molecules are synthesized at
levels (counted as molecules per generation) perfectly cor-
related with their stoichiometry within the complexes in E.
coli and yeast. Li G-W, Burkhardt D, Gross C, Weissman
JS: Quantifying absolute protein synthesis rates reveals prin-
ciples underlying allocation of cellular resources. Cell 2014,
157:624–635.
Concering the reference http://www.biomedcentral.com/
1752-0509/2/1 (i.e. Semple JI, Vavouri T, Lehner B. A sim-
ple principle concerning the robustness of protein complex
activity to changes in gene expression. BMC Syst Biol. 2008
Jan 2;2:1. doi:10.1186/1752-0509-2-1 our point of view on
this specific paper has been published in Veitia RA. On
gene dosage balance in protein complexes: a comment on
Semple JI, Vavouri T, Lehner B. A simple principle concern-
ing the robustness of protein complex activity to changes in
gene expression. BMC Syst Biol. 2009 Jan 30;3:16.
doi:10.1186/1752-0509-3-16.
3) In some places the manuscript is slightly redundant
arguing the same fact/observation in more or less the
same wordings. This should be edited.
Authors’ response: We have tried to avoid redundancies.
Reviewer’s report 3
Reviewer 3. Reviewer Csaba Pal.
I must say I found the paper rather confusing. The au-
thors viewpoint is biased. They posit that “The GDBH
(gene dosage balance hypothesis) explains genetic domin-
ance and several of its evolutionary consequences”. This
may indeed be so, but the hypothesis is not universally
accepted.
Authors’ response: To avoid a lengthy dicussion on the
GDBH we have simply removed the sentences in question
because they are not central to the point developed here.
Yet, dosage balance at the protein level is obvious as dem-
onstrated in Li G-W, Burkhardt D, Gross C, Weissman JS:
Quantifying absolute protein synthesis rates reveals princi-
ples underlying allocation of cellular resources. Cell 2014,
157:624–635.
Most notably, an important prediction of the theory is
that both underexpression and overexpression of protein
complex subunits should lower fitness.
Authors’ response: This is absolutely not the case and a
discussion of the topic is provided in Veitia RA. On gene
dosage balance in protein complexes: a comment on Sem-
ple JI, Vavouri T, Lehner B. A simple principle concerning
the robustness of protein complex activity to changes in
gene expression. BMC Syst Biol. 2009 Jan 30;3:16.
doi:10.1186/1752-0509-3-16. See also Dopman EB, Hartl
DL. A portrait of copy-number polymorphism in Drosoph-
ila melanogaster. Proc Natl Acad Sci U S A. 2007 Dec
11;104(50):19920–5. and many others.
As regards overexpression, the data is not clear cut, and
the two best systematic studies disagree whether protein
complex subunits are especially prone to gene overexpres-
sion (Sopko et al. 2006, Makanae et al. 2013). Moreover, in
contrast to expectation of the GDBH, in most cases the
overexpression phenotypes differ from loss-of-function
phenotypes. Alternative theories may also explain many of
the patterns which seem consistent with the theory. For ex-
ample, the primary mechanism of haploinsufficiency (i.e.
fitness loss of heterozygous for a loss-of-function allele) in
yeast could be due to insufficient protein production, rather
than due to dosage imbalance per se (Deutschbauer et al.
2005).
Authors’ response: Haploinsufficiency by insufficient
protein production is difficult to disentangle from a bal-
ance effect because an insufficient level is needed to
cause an imbalance. A comparison of haploinsufficiency
in a diploid to a euploid haploid state that is normal for
that trait argues for a balance at least on some level.. So
there is still room for imbalances leading to non linear-
ities (be it a the level of protein complexes or cellular
networks) yet to be studied.
So, despite publishing a paper supporting GDBH (Papp et
al. 2003), in the light of the new data, I think the general role
of the theory in genetic dominance is far from clear, to say
the least. Regretfully, this paper (and many prior reviews by
the same authors) ignore all these problems.
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Authors’ response: These comments reflect that there is
debate in the field. The reviewer ignores tens of papers
(too many to be cited here) dealing with protozoa,
Drosophila and plant data lending credence to the GDBH.
We also note that we still have to better understand the
many complexities involved with genomic balance, which
include the discussion raised in this manuscript.
The field needs more systematic and genome-scale works
which directly test these central issues in yeast and other
organisms. Case studies and mathematical models have
probably less important role at this stage.
Authors’ response: We agree that the field needs more
work but it will be difficult to understand the underlying
mechanisms of dominance (or buffering) without having at
least working models. This is our aim here.
I may be wrong, but I had the feeling that the current
manuscript shows substantial overlap with a previously
published paper by one of the authors (Veitia 2010). It
was not at all clear to me what the new and distinguishing
predictions of the current paper are and how could they be
studied experimentally in the future.
Authors’ response: The author is incorrect. There is no
substantial overlap with the paper Veitia 2010. Only the
case “When the reaction of production of AB is reversible
and AB is not degradable.” overlaps to make the present
paper self-contained (yet the mathematical derivation is dif-
ferent). Our main prediction (that we feel is obvious from
reading the paper) is that the effect of a heterozygous de-
letion/duplication of one allele encoding a complex com-
ponent may be buffered that protein level. This can now
be tested by proteomics.
The importance of protein degradation and/or conform-
ational inactivation for buffering is a potentially interesting
thought, but it is very superficial at the moment, and relies
heavily on results of prior papers.
Authors’ response: We believe that although our paper is
purely theoretical, it will point to proteolysis/inactivation as
potential mechanisms fostering buffering against gene dos-
age changes.
All in all, I think this paper only scratched the surface of
an important problem, as it lacks clear guidelines for future
studies. The authors should at the very least try to explore
the idea of “assessing protein levels for cells carrying hetero-
zygous single-gene deletions or duplications when transcrip-
tional dosage compensation is ruled out”. As it stands, it is
only a vague statement.
Authors’ response: The referee is correct and it is difficult
to propose a typical (proteome-wide) experiment because
the expected results depend on the stoichiometry and the
topology of the complex. Besides, the experimenter needs to
be able to determine the amount of final complex in the
WT and mutated situation, which requires not only brute
force proteomics but also extensive knowledge of the bio-
chemistry of the complex(es) in question.
Author’s response to the second round of review
We would like to thank the referees again for their com-
ments and suggestions that we addressed as follows:
Reviewer 1, Dr Eugene Koonin, has not returned any
additional comments on your manuscript.
Reviewer’s report 2
Reviewer 2. Berend Snel
After having read the rebuttal and the revisions, I
would like to make the following points. 1) I still do not
see the relevance or urgency of the model presented in
this paper. Insofar as I now understand the manuscript
and the rebuttals, the papers mentioned by the author
themselves and by the referees, do show the relevance of
the general problem - dosage effects on phenotype-, but
apparently the very same papers do not bear direct rele-
vance on the precise model presented here.
Authors’ response: The referee is right when he says
there is no urgency for this model. It simply brings up a
possibility of buffering that can explain why heterozygous
deletions of genes encoding components of macromolecu-
lar complexes do not always lead to an abnormal pheno-
type (i.e. the wild-type allele is dominant). As already said,
the idea behing this model is not to provide a quantitative
appraisal of the papers mentioned in the manuscript.
2) After reading the discussion between the other ref-
erees and the authors, and some further reading I now
think the model and its result are not as new as I thought
in first instance. A similar model with similar results was
published by one of the authors of the current paper in
the Journal of Theoretical Biology in 2003. To me the
current manuscript is similar to the older paper because
the JTB paper also shows some degree of “free buffering”
when considering statically regulated protein concentra-
tions forming into protein dimers.
Authors’ response: The referee is right when he says
that the results between the JTB 2003 paper and the
present one are similar. The interesting thing is that in
the first case, the basis of the buffer effect is pure “mass
action”. In the present case, the important and novel
element is protein degradation or conformational inacti-
vation. We hope the reader will understand that the
models are obviously different even if the results are
similar.
Reviewer’s report 3
Reviewer 3. Reviewer Csaba Pal.
I have no further comments on this manuscript. There
are several key point in the authors’ response I disagree
with (most particularly major predictions of the dosage
balance theory), but discussing them would go beyond
the scope of the manuscript.
Authors’ response: It would be interesting to know
which are “the major predictions of the dosage balance
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theory” Dr. Pal refers to because there are many predic-
tions in the literature said to stem from the GDBH that
are either wrong or not justified. We agree with him that
this discussion would be beyond the narrow scope of
our theoretical paper but we would be delighted to fur-
ther discuss on this matter with the referee.
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